Turn Therapeutics (TTRX) Operating Leases (2024 - 2026)

Turn Therapeutics has reported Operating Leases for 3 years, with the latest figure at $21539.0 in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $21539.0; the trailing twelve-month figure through Mar 2026 stood at $21539.0 (changed N/A YoY), and the FY2025 full-year result was $34081.0, down 57.6% from the prior year.
• Operating Leases for Q1 2026 stood at $21539.0, down from $34081.0 in the prior quarter.
• The five-year high for Operating Leases was $80376.0 in Q4 2024, with the low at $21539.0 in Q1 2026.
• Average Operating Leases over 3 years is $45585.0, with a median of $40212.5 recorded in 2025.
• Peak annual rise in Operating Leases reached 57.6% in 2025, while the deepest fall reached 57.6% in 2025.
• Tracing TTRX's Operating Leases over 3 years: stood at $80376.0 in 2024, then slumped by 57.6% to $34081.0 in 2025, then sank by 36.8% to $21539.0 in 2026.
• The last three Operating Leases figures came in at $21539.0 (Q1 2026), $34081.0 (Q4 2025), and $46344.0 (Q3 2025), per Business Quant data.

Peer Comparison